REC-1/RFP-Luciferase stable cell line

REC-1/RFP-Luciferase cells are derived from the human B-cell lymphoma cell line REC-1 by stably integration of a constitutive RFP-Firefly luciferase stably expression construct. REC-1 is derived from a patient with mantle cell lymphoma (MCL), making it a valuable model for studying this specific type of lymphoma. REC-1 cells are used to investigate the molecular pathways involved in MCL pathogenesis, including the role of cyclin D1 in cell cycle regulation, as well as to evaluate the efficacy of new therapeutic agents, including chemotherapy and targeted therapies. REC-1/RFP-Luciferase cells stably stably express RFP and firefly luciferase, can be used for in vitro assays and in vivo imaging.